Related Experiment Video
Updated: May 12, 2026

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
Published on: June 5, 2020
Risk factors for hepatitis C transmission in HIV patients, Hepacam study, ANRS 12267 Cambodia
Sophie Goyet1, Nathalie Lerolle, Isabelle Fournier-Nicolle
1Epidemiology and Public Health Unit, Pasteur Institute in Cambodia, 5, Boulevard Monivong, BP 983, Phnom Penh, Cambodia, sophiegoyet@gmail.com.
Insights
Hepatitis C Virus (HCV) infection in people living with HIV/AIDS (PLHIV) in Cambodia is linked to age, past surgeries, and parenteral exposures. Enhanced infection control and screening are crucial for this vulnerable population.
Area of Science:
- * Infectious Diseases
- * Public Health
- * Epidemiology
Background:
- * Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) share common transmission routes.
- * Understanding HCV transmission dynamics in HIV-positive individuals is critical for effective prevention and management.
Purpose of the Study:
- * To investigate the specific routes and risk factors for HCV transmission among people living with HIV/AIDS (PLHIV) in Cambodia.
- * To identify key factors associated with HCV/HIV co-infection.
Main Methods:
- * A case-control study conducted in 2009 involving 44 HCV/HIV co-infected cases and 160 HIV mono-infected controls.
- * Data collection included medical history, focusing on exposure to parenteral infusions, surgery, and fibroscopy.
- * Multivariate analysis was employed to determine factors associated with co-infection.
Main Results:
- * Older age (>50 years) was significantly associated with HCV/HIV co-infection (OR 5.4, 95% CI 1.5-19.6).
- * Exposure to multiple parenteral infusions before 2000 (OR 3.4, 95% CI 1.5-7.6), surgery (OR 2.6, 95% CI 1.2-5.7), and fibroscopy (OR 2.4, 95% CI 1.0-5.7) were identified as significant risk factors.
- * These factors highlight potential iatrogenic or nosocomial transmission routes.
Conclusions:
- * The study underscores the necessity of implementing routine HCV screening for PLHIV.
- * Strengthening national infection control guidelines and raising public awareness about the risks of parenteral medications are essential.
- * Targeted interventions are needed to reduce HCV transmission within the PLHIV population in Cambodia.
Abstract:
In 2009, we conducted a case-control study to explore the routes of HCV transmission in people living with HIV/AIDS (PLHIV) in Cambodia. Cases were HCV/HIV co-infected patients (who tested RT-PCR positive for HCV-RNA or had confirmed presence of HCV antibodies) (n = 44). Controls were HIV mono-infected patients, with no HCV antibodies (n = 160). They were recruited among the PLHIV presenting at one national reference centre of HIV/AIDS. Multivariate analysis showed that factors associated with the co-infection were the age older than 50 years (OR 5.4, 95 % confidence interval (CI) 1.5-19.6), the exposure to multiple parenteral infusions before the year 2000 (OR 3.4, 95 % CI 1.5-7.6), to surgery (OR 2.6, 95 % CI 1.2-5.7) and to fibroscopy (OR 2.4, 95 % CI 1.0-5.7). These results show the need to implement HCV screening in PLHIV, to support the implementation of national infection control guidelines, and to reinforce public awareness on the risks linked to parenteral medications.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Retrovirus Life Cycles
Sexually Transmitted Infections
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...